Michael Baker (BKR) Terminates 'Poison Pill'
Tweet
Share
E-mailGet Alerts BKR Hot Sheet
Join SI Premium – FREE
Michael Baker Corporation (AMEX: BKR) reports that its Board of Directors had approved an amendment to the Company’s shareholder rights plan to accelerate the final expiration date of the rights under the plan to March 30, 2012.
This amendment has the effect of terminating the plan, which is commonly referred to as a “poison pill.” Shareholders do not have to take any action as a result of this termination and this action will have no effect on the Company’s common stock.
This amendment has the effect of terminating the plan, which is commonly referred to as a “poison pill.” Shareholders do not have to take any action as a result of this termination and this action will have no effect on the Company’s common stock.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tidewater completes acquisition of Wilson Sons Ultratug
- KeyCorp names Chris Doll as chief strategy officer and deputy CFO
- Helix shareholders approve merger with Hornbeck Offshore Services
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
